Navigation Links
Iressa as Good as Chemotherapy for Lung Cancer
Date:11/21/2008

Daily pill easier to take, has fewer side effects than chemotherapy, experts say

FRIDAY, Nov. 21 (HealthDay News) -- The cancer-fighting pill Iressa works as well as chemotherapy as a second-line treatment for lung cancer, researchers report.

Although neither therapy prolongs survival beyond eight months, Iressa (gefitinib) causes fewer serious side effects and may be a better choice for patients who did not do well on their first round of chemotherapy.

"A pill, with less side effects, taken once a day, has similar activity to traditional chemotherapy given by vein every three weeks," said lead researcher Dr. Edward Kim, an assistant professor at the M. D. Anderson Cancer Center in Houston.

This finding should reassure doctors that they are not compromising effective therapy by using a pill, Kim said.

Iressa is not available in the United States, but a similar drug, Tarceva, is.

Iressa was first developed by AstraZeneca, but it failed to meet expectations. The National Cancer Institute ended clinical trials of the drug in 2005 because it failed to prolong the lives of lung cancer patients.

The latest finding has meaning for these patients, however, Kim said. "You can be treated for lung cancer. There are different therapies available, and they have different side-effect profiles," he said. "Chemotherapy will never be eliminated, but we are getting more options for targeted therapy; and people can live as normal a life as they can bearing the weight of lung cancer."

The report was published in the Nov. 22 issue of The Lancet.

In a head-to-head comparison, Kim's team randomly assigned 1,466 lung cancer patients who had undergone previous chemotherapy to daily doses of Iressa or the chemotherapy drug docetaxel once every three weeks.

The researchers found that survival in both groups of patients was about the same. Median survival for those taking Ir
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy
2. Chemotherapy may be culprit for fatigue in breast cancer survivors
3. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
4. To evade chemotherapy, some cancer cells mimic stem cells
5. New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas
6. PET scans can accurately detect a breast tumors response to chemotherapy
7. Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
8. Medicare modernization act did not change chemotherapy as feared
9. HER-2 status predicts success of chemotherapy in breast cancer treatment, study finds
10. Cancer conflict with chemotherapy treatment
11. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Iressa as Good as Chemotherapy for Lung Cancer
(Date:8/27/2015)... ... August 27, 2015 , ... In ... legal marijuana industry with the launch of its Doobster platform, a HIPAA-compliant mobile ... order products from their smart phones and tablets. Well, Doobster, “The App ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... scheduled for October 27-29, 2015 in San Jose, CA. The first event ... focus on the void that exists where battery development and energy storage innovation ...
(Date:8/27/2015)... ... August 27, 2015 , ... In addition to its existing Doctor of ... third doctoral program at its main campus in Reading: Doctor of Nursing Practice. , ... to prepare advanced practice nurses for the highest level of clinical nursing practice. ...
(Date:8/27/2015)... ... August 27, 2015 , ... Florida Hospital North Pinellas, located at 1395 South Pinellas Avenue ... of 2016. The new facility will be located at US Highway 19 North and Highlands ... on August 18, and work on the project is slated to begin in September 2015. ...
(Date:8/27/2015)... ... , ... NetDimensions is once again named among TrainingIndustry.com’s annual Top ... only to effectively deliver, curate and administer great programs, but also measure the impact ... six consecutive years, NetDimensions has maintained its position on this Top 20 list. This ...
Breaking Medicine News(10 mins):Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 2Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 3
... States added farm-raised fish and shrimp to a growing list ... Thursday. ,The US Food and Drug Administration ... until importers could prove the shipments were free of unsafe ... urged a recall of up to 450,000 Chinese tires because ...
... south Florida has found that Rheumatologists substantially overestimate ... which may lead to inaccurate evaluations ... for lifestyle modifications. ,The rheumatologists consistently ... in performing activities of daily living, such as ...
... labeled as a mentally ill person, which can ... result in a higher rate of unemployment, lower earnings ... Each year, one in four U.S. adults suffers from ... of Mental Health. ,In a recently published ...
... Gehrig's disease mystery, UCLA, Italian chemists may have solved ... key role in a particular form of amyotrophic ... a progressive, fatal neuro-degenerative disorder that strikes without warning. ... and biochemistry, has studied the protein copper-zinc superoxide dismutase ...
... order can rest assured that their male offspring will take after ... to the daughters, especially in the case of red deer. ... that may prove useful for their sons, may not have the ... ,The boffins also state that though this study was carried out ...
... flower essences, is an effective stress reliever which neither ... to any side effects or addiction, says a scientific ... five flower essences-Rock Rose to alleviate terror and panic, ... inattentiveness, Star of Bethlehem to ease shock, and Cherry ...
Cached Medicine News:Health News:US to Detain Seafood Imports from China 2Health News:Rheumatologists Underestimate the Patients Ability to Work 2Health News:Boffins a Step Closer to Solving Puzzle of Lou Gehrig's Disease 2Health News:Boffins a Step Closer to Solving Puzzle of Lou Gehrig's Disease 3Health News:Successful Dads Have Not So Successful Daughters 2
(Date:8/27/2015)... , August 27, 2015 Itamar ... a private investment in public equity (PIPE) deal, in ... million in Itamar Medical.   Through this ... of Itamar Medical and will work closely with the ... According to the investment agreement, Itamar Medical will ...
(Date:8/27/2015)... Aug. 27, 2015  Zimmer Biomet Holdings, Inc. (NYSE ... announced that it will be participating in the Goldman ... Goldman Sachs offices in London ... Company Founded in 1927 and headquartered in ... leader in musculoskeletal healthcare.  We design, manufacture and market ...
(Date:8/27/2015)... British Columbia and MENLO PARK, ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), ... of new cancer therapies, today announced that it will ... ending June 30, 2015 on Friday, September 4, 2015. ... business update conference call and live webcast for investors, ...
Breaking Medicine Technology:Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 2Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 3Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 4Viola Private Equity Invests up to $28.4 Million in Itamar Medical and Becomes the Largest Shareholder of the Company 5DelMar Pharmaceuticals to Announce Fiscal 2015 Year-End Financial Results on September 4, 2015 2DelMar Pharmaceuticals to Announce Fiscal 2015 Year-End Financial Results on September 4, 2015 3
... Oct. 14 ZyStor Therapeutics, Inc., a biotechnology company ... the treatment of Lysosomal Storage Diseases using the Company,s ... it has received clearance from the U. S. Food ... for its first drug candidate, ZC-701, an enzyme replacement ...
... Company (NYSE: LLY ) today announced the sale ... AG, one of the world,s largest chemical companies. The ... operation with a focus on producing high-quality active pharmaceutical ... In connection with the sale of the site, the ...
Cached Medicine Technology:ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 2ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 2Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 4
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
Medicine Products: